According to the latest market report published by Credence Research, Inc. “Cell-free Protein Expression Market – Growth, Future Prospects, and Competitive Analysis, 2017 – 2025,” the global cell-free protein expression market was valued at US$ 167.2 Mn in 2016, and is expected to reach US$ 282.3 Mn by 2025, expanding at a CAGR of 5.9% from 2017 to 2025.
The purpose of the report is to illustrate the state of the market of Sterile Injectables, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.
Browse here for full report: https://www.credenceresearch.com/report/cell-free-protein-expression-market
A cell-free protein expression method synthesizes protein without the use of living cells. Cell free protein expression system is used for protein analysis and study biochemical process. It transcribes DNA into RNA and further translates RNA to protein by in-vitro solution made up from selective cell lysate type. They are not used where the high yield of protein synthesis required, while it preferred when small amount of recombinant protein is desired. Conventionally various cell lysate E.coli, wheat germ have being used, while recently mammalian cell lysate is being considered as the best choice for protein synthesis. Commercialisation of cell free protein system, rise in research activities in pharma sector, demand of biologics are significant factors contributing to the growth of cell free protein expression market.
The global cell-free protein expression market is segmented by product type into E. coli cell-free protein expression system, rabbit reticulocytes cell-free protein expression system, wheat germ cell-free protein expression system, insect cells cell-free protein expression system, mammalian cell-free protein expression system, and consumables. Mammalian cell free protein expression method is anticipated to be the most fast growing segment of cell protein expression market. The global cell-free protein expression market is segmented by application type into enzyme engineering, protein labelling, protein-protein interaction and protein purification. Protein- protein interaction segments dominates the largest share of the cell free protein market expression. It also segmented by expression mode into continuous flow expression and batch expression. Continuous flow expression system occupies large share of cell free protein expression market, and it’s expected to continue the growth during the forecast period.
As of the current market scenario, North America dominated the global cell-free protein expression market followed by the European market. Well established research and development infrastructure, rise in funding in proteomics and genomics study and demand of biologics drive the North American market. Additionally, major biopharmaceutical and biotechnological companies are based in this region, further fuelling the cell-free protein expression market. Asia-Pacific is fastest growing cell free protein expression market in forecast period.
Market Competition Assessment:
Key players in the global cell-free protein expression market are Bioneer Corporation, Biotechrabbit GmbH, CellFree Sciences Co., Cube Biotech GmbH, GeneCopoeia, Inc., Jena Bioscience GmbH, New England Biolabs, Promega Corporation, Takara Bio,Inc, Thermo Fisher Scientific, and others.
Why was the report written?
This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Sterile Injectables buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.
What is the current market landscape and what is changing?
Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.
The report on the market of Cell-Free Protein Expression contains:
Analysis and forecast of Sterile Injectables market dynamics;
Analysis of domestic production, market shares of the main market players;
Analysis of exports and imports;
Analysis of factors, leading the development of the Sterile Injectables market;
Assessment and forecast of Sterile Injectables market development;
Financial and business profiles of the leading companies in the Sterile Injectables industry.
– Up to date working Sterile Injectables data by major regions in the world, the forecast of planned capacity additions by 2026
– The annual breakdown of capital expenditure spending on proposed Sterile Injectables for the period 2018 to 2026
– Planned Sterile Injectables additions and capital expenditure spending by key countries and companies across the world
– Planned capital expenditure spending on new Sterile Injectables projects by region, key countries, and companies
– Details of major planned Sterile Injectables projects in the world up to 2026
Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/58536
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Credence Research Inc.
105 N 1st ST #429
Toll Free (US/CANADA): +1-800-361-8290